1-20 of 40
Daphne de Jong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

DNA or RNA? Classification of B-cell lymphomas

Bauke Ylstra, Daphne de Jong
Journal: Blood
Blood (2023) 141 (20): 2413–2415.
https://doi.org/10.1182/blood.2022018741
Published: 2023
Journal Articles

Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Janneke A. Eken, Marvyn T. Koning, Julieta H. Sepulveda Yanez, Cornelis A.M. van Bergen, Edwin Quinten, Kristyna Kupcova, Ondrej Havranek, Ruben A.L. De Groen, Joost S.P. Vermaat, Daphne de Jong, Philip Kluin, Arjen Cleven, Hassan Jumaa, Hendrik Veelken
Journal: Blood
Blood (2022) 140 (Supplement 1): 6444–6445.
https://doi.org/10.1182/blood-2022-159420
Published: 2022
Journal Articles

Immune Profiling of Double and Triple Hit High Grade B Cell Lymphoma Patients Treated with DA-EPOCH Reveals Activation of T Cells and Reduced T Cell Exhaustion

A.Vera de Jonge, Carolien Duetz, Wassilis S.C. Bruins, Erik D. van Werkhoven, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara P.W. Klerk, Yorick Sandberg, Rob Fijnheer, Pim Mutseaers, Djamila E. Issa, Lara H. Böhmer, Roel J.W. Van Kampen, Otto J. Visser, Daphne de Jong, Josée M. Zijlstra, Tuna Mutis, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 9298–9299.
https://doi.org/10.1182/blood-2022-163068
Published: 2022
Journal Articles

Plasma Extracellular Vesicle-Associated microRNAs for Early Response Prediction in Patients with High-Grade B-Cell Lymphoma

Steven Wang, Esther E.E. Drees, Cristina Gómez-Martín, A. De Jonge, Monique van Eijndhoven, Nils Groenewegen, Sandra Veldt-Verkuijlen, Marcel Nijland, Marjolein W.M. Van Der Poel, Yorick Sandberg, Rozemarijn van Rijn, Pim Mutsaers, Vibeke K.J. Vergote, Marie José Kersten, Yavuz M. Bilgin, Wendy B.C. Stevens, Marc Durian, Tjeerd J.F. Snijders, Daphne de Jong, Josée M. Zijlstra, Martine E.D. Chamuleau, Dirk Michiel Pegtel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3523–3524.
https://doi.org/10.1182/blood-2022-165494
Published: 2022
Journal Articles

A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC -Rearranged DLBCL Patients

A. Vera de Jonge, Erik D. van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G.G.M. Rutten, Rogier Mous, Joost S.P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry R. Koene, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 2059–2060.
https://doi.org/10.1182/blood-2022-163204
Published: 2022
Journal Articles

The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma

Erik Van Dijk, Jurriaan Janssen, Matias Mendeville, G. Tjitske Los-De Vries, Margaretha GM Roemer, Phylicia Stathi, Julia Richter, Yong Soo Kim, Wolfram Klapper, Ulrich Dührsen, Andreas Hüttmann, P. J Lugtenburg, Josée M. Zijlstra, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau, Bauke Ylstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 9261–9263.
https://doi.org/10.1182/blood-2022-160052
Published: 2022
Journal Articles

Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma: Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial

Marie José Kersten, Martin Dreyling, Kim M. Linton, Dana Chitu, Sanne Tonino, Marcel Kap, Roberto D Liu, Martine E.D. Chamuleau, Hein P.J. Visser, Eva De Jongh, Erik WAF Marijt, Maria B.L. Leijs, Yavuz M. Bilgin, Jan Dürig, Pamela McKay, Tjeerd J.F. Snijders, Andrew Pettitt, Monique C. Minnema, Gabriele Prange-Krex, Maria Cuijpers, Lara H. Böhmer, Lidwine W. Tick, Axel Florschütz, Matthijs Silbermann, Rob Fijnheer, Aart Beeker, Nelleke Tolboom, Cristina Mitea, Anne IJ Arens, Gerben JC Zwezerijnen, Wolfram Klapper, Sarah E. Coupland, Daphne de Jong, Jeanette K. Doorduijn, Josée M. Zijlstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 2283–2285.
https://doi.org/10.1182/blood-2022-156085
Published: 2022
Journal Articles

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial

A. Vera de Jonge, Erik D. van Werkhoven, Marcel Nijland, Koen de Heer, Marjolein W.M. Van Der Poel, Yorick Sandberg, Clara Klerk, Esther E.E. Drees, Margaretha GM Roemer, Daphne de Jong, D. Michiel Pegtel, Bronno van der Holt, Tuna Mutis, Josée M Zijlstra, Marie José Kersten, Martine E.D Chamuleau
Journal: Blood
Blood (2021) 138 (Supplement 1): 1414.
https://doi.org/10.1182/blood-2021-146812
Published: 2021
Journal Articles

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Jakoba J Eertink, Gerben J.C Zwezerijnen, Sanne E Wiegers, Martine E.D Chamuleau, Pieternella Lugtenburg, Daphne De Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Andreas Hüttmann, Christine Schmitz, Julia Richter, Wolfram Klapper, Otto S Hoekstra, Henrica C.W de Vet, Ronald Boellaard, Josée M Zijlstra
Journal: Blood
Blood (2021) 138 (Supplement 1): 451.
https://doi.org/10.1182/blood-2021-145855
Published: 2021
Journal Articles

Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma

CME Clinical Trials & Observations Brief Report
G. Tjitske Los-de Vries, Mintsje de Boer, Erik van Dijk, Phylicia Stathi, Nathalie J. Hijmering, Margaretha G. M. Roemer, Matias Mendeville, Daniel M. Miedema, Jan Paul de Boer, Hinne A. Rakhorst, Flora E. van Leeuwen, René R. W. J. van der Hulst, Bauke Ylstra, Daphne de Jong
Journal: Blood
Blood (2020) 136 (25): 2927–2932.
https://doi.org/10.1182/blood.2020005372
Published: 2020
Includes: Supplemental data
Journal Articles

Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast

Clinical Trials & Observations
Mintsje de Boer, Michael Hauptmann, Nathalie J. Hijmering, Carel J. M. van Noesel, Hinne A. Rakhorst, Hanne E. J. Meijers-Heijboer, Jan Paul de Boer, René R. W. J. van der Hulst, Daphne de Jong, Flora E. van Leeuwen
Journal: Blood
Blood (2020) 136 (11): 1368–1372.
https://doi.org/10.1182/blood.2019004498
Published: 2020
Includes: Supplemental data
Journal Articles

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo , Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J Van Der Horst, MSc, A. Vera de Jonge, Ida H Hiemstra, PhD, Anne T Gelderloos, MSc, Daniella RAI Berry, Nathalie J Hijmering, Daphne de Jong, Prof Dr, Martine E.D. Chamuleau, Sonja Zweegman, MD PhD, Esther CW Breij, DPhil, Margaretha GM Roemer, PhD, Tuna Mutis
Journal: Blood
Blood (2019) 134 (Supplement_1): 4066.
https://doi.org/10.1182/blood-2019-125765
Published: 2019
Journal Articles

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Brief Report
Suraya Elfrink, Charlotte M. de Winde, Michiel van den Brand, Madeleine Berendsen, Margaretha G. M. Roemer, Frank Arnold, Luuk Janssen, Alie van der Schaaf, Erik Jansen, Patricia J. T. A. Groenen, Astrid Eijkelenboom, Wendy Stevens, Corine J. Hess, J. Han van Krieken, Joost S. P. Vermaat, Arjen H. G. Cleven, Ruben A. L. de Groen, Viviana Neviani, Daphne de Jong, Sjoerd van Deventer, Blanca Scheijen, Annemiek B. van Spriel
Journal: Blood
Blood (2019) 134 (12): 946–950.
https://doi.org/10.1182/blood.2019001185
Published: 2019
Includes: Supplemental data
Journal Articles

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

David Martín-Garcia, Alba Navarro, Rafael Valdés-Mas, Guillem Clot, Jesús Gutiérrez-Abril, Miriam Prieto, Inmaculada Ribera-Cortada, Renata Woroniecka, Grzegorz Rymkiewicz, Susanne Bens, Laurence de Leval, Andreas Rosenwald, Judith A. Ferry, Eric D. Hsi, Kai Fu, Jan Delabie, Dennis Weisenburger, Daphne de Jong, Fina Climent, Sheila J. O’Connor, Steven H. Swerdlow, David Torrents, Sergi Beltran, Blanca Espinet, Blanca González-Farré, Luis Veloza, Dolors Costa, Estella Matutes, Reiner Siebert, German Ott, Leticia Quintanilla-Martinez, Elaine S. Jaffe, Carlos López-Otín, Itziar Salaverria, Xose S. Puente, Elias Campo, Sílvia Beà
Journal: Blood
Blood (2019) 133 (9): 940–951.
https://doi.org/10.1182/blood-2018-07-862151
Published: 2019
Includes: Supplemental data
Journal Articles

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma

Matias Mendeville, Margaretha G. M. Roemer, Mari F. C. M. van den Hout, G. Tjitske Los-de Vries, Reno Bladergroen, Phylicia Stathi, Nathalie J. Hijmering, Andreas Rosenwald, Bauke Ylstra, Daphne de Jong
Journal: Blood
Blood (2019) 133 (4): 377–380.
https://doi.org/10.1182/blood-2017-12-822171
Published: 2019
Includes: Supplemental data
Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 786.
https://doi.org/10.1182/blood-2018-99-110240
Published: 2018
Journal Articles

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Clinical Trials & Observations
Yasodha Natkunam, Dita Gratzinger, Amy Chadburn, John R. Goodlad, John K. C. Chan, Jonathan Said, Elaine S. Jaffe, Daphne de Jong
Journal: Blood
Blood (2018) 132 (18): 1871–1878.
https://doi.org/10.1182/blood-2018-04-842559
Published: 2018
Journal Articles

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Anne M. R. Schrader, Patty M. Jansen, Rein Willemze, Maarten H. Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F. Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie José Kersten, Michiel van den Brand, Wendy B. C. Stevens, Daphne de Jong, Myrurgia Abdul Hamid, Bea C. Tanis, Eduardus F. M. Posthuma, Marcel Nijland, Arjan Diepstra, Steven T. Pals, Arjen H. G. Cleven, Joost S. P. Vermaat
Journal: Blood
Blood (2018) 131 (18): 2086–2089.
https://doi.org/10.1182/blood-2017-12-822817
Published: 2018
Includes: Supplemental data
Journal Articles

First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands

Martine Chamuleau, MD PhD, Marcel Nijland, MD, Niek Lamers, Nathalie Hijmering, Dana Chitu, Josée Zijlstra, MD, Otto Visser, MDPhD, Josephine M. Vos, MD, Henriette Berenschot, MD, Rinske Boersma, MD, Marie Jose Kersten, MD PhD, Daphne de Jong, Prof Dr
Journal: Blood
Blood (2017) 130 (Supplement 1): 4144.
https://doi.org/10.1182/blood.V130.Suppl_1.4144.4144
Published: 2017